BRAINCHIP HOLDINGS LIMITED (BRN)
Share Price Analysis and Chart
Enter the company code or Name for stock analysis:
BRN - BRAINCHIP HOLDINGS LIMITED
FNArena Sector : Medical Equipment & Devices
Year End: June
GICS Industry Group : Software & Services
Debt/EBITDA: N/A
Index: ASX300 | ALL-ORDS | ALL-TECH
Brainchip Holdings is a holding company for its subsidiaries which provide neural computing technology and artificial neural networks through digital hardware and software. It operates in Australia and the US and has been a listed company since 2011.
| LAST PRICE | CHANGE +/- | CHANGE % | VOLUME |
|---|---|---|---|
|
$0.195
06 Nov |
0.000 OPEN $0.20 |
0.000 HIGH $0.20 |
0 LOW $0.20 |
| OTHER COMPANIES IN THE SAME SECTOR | |||
| 4DX . AT1 . AYA . BB1 . CAT . CBL . CGS . CMP . COH . CSX . CU6 . CVB . CYC . EBR . EMV . EYE . FPH . IME . IMR . IPD . LDX . MX1 . NAN . ONE . PCK . PEB . PGC . PME . RMD . SOM . TRJ . UBI . | |||
FNARENA'S MARKET CONSENSUS FORECASTS
- No Record -
HISTORICAL DATA ARE ALL IN AUD
Copyright © 2025 FactSet UK Limited. All rights reserved
EPS Basic
- Negative
- Growth
- Slowing
DPS All
- Negative
- Growth
- Slowing
Sales/Revenue
- Negative
- Growth
- Slowing
Book Value Per Share
- Negative
- Growth
- Slowing
Net Operating Cash Flow
- Negative
- Growth
- Slowing
Net Profit Margin
- Negative
- Growth
- Slowing
Return on Capital Employed
- Negative
- Growth
- Slowing
Return on Invested Capital
- Negative
- Growth
- Slowing
Return on Assets
- Negative
- Growth
- Slowing
Return on Equity
- Negative
- Growth
- Slowing
Return on Total Capital
- Negative
- Growth
- Slowing
Free Cash Flow ex dividends
- Negative
- Growth
- Slowing
Short-Term Debt
- Negative
- Growth
- Slowing
Long Term Debt
- Negative
- Growth
- Slowing
Total Debt
- Negative
- Growth
- Slowing
Goodwill - Gross
- Negative
- Growth
- Slowing
Cash & Equivalents - Generic
- Negative
- Growth
- Slowing
Price To Book Value
- Negative
- Growth
- Slowing
Capex
- Negative
- Growth
- Slowing
Capex % of Sales
- Negative
- Growth
- Slowing
Cost of Goods Sold
- Negative
- Growth
- Slowing
Selling, General & Admin. Exp & Other
- Negative
- Growth
- Slowing
Research & Development
- Negative
- Growth
- Slowing
Investments - Total
- Negative
- Growth
- Slowing
EXPERT VIEWS
Display All Commentary
Sentiment Indicator
No. Of Recommendations
EXTRA COVERAGE
Display All Commentary
No. Of Recommendations
Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.
BRN STOCK CHART
FNArena News on BRN
| 1 |
Next Week At A Glance – 10-14 Nov 2025Nov 07 2025 - Weekly Reports |
| 2 |
ESG Focus: The Little Big Things – 19-12-2024Dec 23 2024 - ESG Focus |
| 3 |
The Short Report – 07 Sep 2023Sep 07 2023 - Weekly Reports |
| 4 |
Next Week At A Glance – 22-26 May 2023May 19 2023 - Weekly Reports |
| 5 |
Artificial Intelligence On The ASXMay 02 2023 - Small Caps |
Latest Medical Equipment & Devices News
| 1 |
Tariff Uncertainty Negates ResMed’s Q1 PositivesNov 05 2025 - Australia |
| 2 |
Acquisition Loads Up CatapultOct 20 2025 - Small Caps |
| 3 |
Cochlear’s Future In Nexa’s HandsAug 19 2025 - Australia |
| 4 |
ResMed’s New Level Of SupportJul 29 2025 - Technicals |
| 5 |
Strength To ‘AI’ Strength For Pro MedicusJul 10 2025 - Australia |
| 6 |
Cochlear Downgrades Ahead Of New LaunchesJun 19 2025 - Australia |
| 7 |
Fisher & Paykel Healthcare’s Tariffs AnnoyanceJun 04 2025 - Australia |
| 8 |
ResMed’s Margin Expansion & Tariff ExemptionApr 28 2025 - Australia |
| 9 |
Trend Remains Up For Catapult InternationalFeb 18 2025 - Technicals |
| 10 |
ESG Focus: Top ASX Companies, Superbugs & HydrogenFeb 07 2025 - ESG Focus |